Designed to support retroviral load management to manage CD4 cell levels and alleviate risk of opportunistic infections.
Mechanism of Action
Incorporates into growing viral DNA, acting as a chain terminator to prevent HIV reverse transcription.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
12–24 hours
Contraindications
Concurrent use of allopurinol or ribavirin, Severe hepatic impairment
Severe Adverse Events
Severe acute pancreatitis — requires immediate medical attention, Lactic acidosis — requires immediate medical attention, Severe hepatomegaly — requires immediate medical attention
Information related to Videx EC is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
